The increased demand for blood thinning drugs – anticoagulants – has created a huge demand among the population for drugs in this group. This led to a sharp increase in requests to the State Enterprise ACADEMPHARM with a request to speed up the sale of the new drug RIVAXAN (anticoagulant, active ingredient – rivaroxaban, an analogue of Ksarelto).
Understanding the importance of this drug in the difficult period of the fight against Covid-19, we hasten to inform you that we did everything possible to speed up the appearance of RIVAKSAN in the pharmacies of Belarus!
The first shipment will begin at the end of January 2021.
